Top Medical Searches

Impax broke U.S. antitrust law by delaying generic drug, jury told

BOSTON (Reuters) – Impax Laboratories Inc went to trial on Monday over allegations by major retailers and consumers that the company agreed to delay launching a generic version of acne medication Solodyn in exchange for millions of dollars from the manufacturer.

 Read more…

Be Sociable, Share!
March 13th, 2018 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us